Patent and Technology License Agreement and Trademark Assignment Between IGL Pharma, Inc. and QSAM Therapeutics Inc.Patent and Technology License Agreement • April 24th, 2020 • Q2Earth Inc. • Specialty cleaning, polishing and sanitation preparations • Texas
This Patent and Technology License Agreement and Trademark Assignment (the “Agreement”) is made and entered into as of April 20, 2020 (the “Effective Date”), by and between IGL Pharma, Inc., a Delaware corporation, (“IGL Pharma”) having its principal place of business at 1004 Velasco Street, Angleton, Texas 77515 and QSAM Therapeutics Inc., (“QSAM”) a Texas corporation having its principal place of business 3616 Far West Blvd, Suite 117-292, Austin, Texas 78731. IGL Pharma and QSAM are each referred to herein as a “Party” and collectively as the “Parties.”
CONSULTING AND CONFIDENTIALITY AGREEMENTConsulting and Confidentiality Agreement • April 24th, 2020 • Q2Earth Inc. • Specialty cleaning, polishing and sanitation preparations • Delaware
This CONSULTING AND CONFIDENTIALITY AGREEMENT (this “Agreement”) is entered into as of April 20, 2020 (the “Effective Date”), by and between IGL Pharma, Inc., a Delaware corporation (“IGL Pharma”) and QSAM Therapeutics Inc., a Texas corporation (“QSAM”).
